110 related articles for article (PubMed ID: 28441715)
1. Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line.
Shi X; Dou Y; Zhou K; Huo J; Yang T; Qin T; Liu W; Wang S; Yang D; Chang L; Wang C
Biomed Pharmacother; 2017 Jun; 90():897-905. PubMed ID: 28441715
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
Wang C; Guo LB; Ma JY; Li YM; Liu HM
Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells.
Wang C; Guo L; Wang S; Wang J; Li Y; Dou Y; Wang R; Shi H; Ke Y; Liu H
Int J Mol Med; 2017 Mar; 39(3):645-653. PubMed ID: 28204832
[TBL] [Abstract][Full Text] [Related]
4. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.
Zhou C; Cheng H; Qin W; Zhang Y; Xiong H; Yang J; Huang H; Wang Y; Chen XZ; Tang J
Oncotarget; 2017 Apr; 8(17):27915-27928. PubMed ID: 28427190
[TBL] [Abstract][Full Text] [Related]
5. PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant.
Duraj J; Takacsova X; Sedlak J; Sulikova M; Hunakova L; Bies J; Chorvath B
Anticancer Res; 2000; 20(6B):4627-32. PubMed ID: 11205313
[TBL] [Abstract][Full Text] [Related]
6. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract][Full Text] [Related]
7. Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells.
Shi X; Qin T; Liu W; Zhang X; Li L; Huo J; Zhou K; Yang D; Zhang Y; Wang C
Biomed Pharmacother; 2017 Dec; 96():1186-1192. PubMed ID: 29196102
[TBL] [Abstract][Full Text] [Related]
8. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Paclitaxel and shMCL-1 by Folic Acid-Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance.
Nie W; Wang B; Mi X; Chen J; Yu T; Miao J; Lin Y; Yang T; Ran M; Hong Z; Liu X; Liang X; Qian Z; Gao X
Small Methods; 2021 May; 5(5):e2001132. PubMed ID: 34928100
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine Sensitizes Esophageal Carcinoma EC109 Cells to Paclitaxel by Inhibiting Autophagy.
Yuan Z; Cai J; Du Q; Ma Q; Xu L; Cai Y; Zhong X; Guo X
Crit Rev Eukaryot Gene Expr; 2023; 33(6):43-53. PubMed ID: 37522544
[TBL] [Abstract][Full Text] [Related]
12. CyclinG1 Amplification Enhances Aurora Kinase Inhibitor-Induced Polyploid Resistance and Inhibition of Bcl-2 Pathway Reverses the Resistance.
Zhang W; Xu J; Ji D; Li Z; He W; Yang F; Lan H; Wang Y; Wu Z; Liu X; Huang S; Li L; Zhou W
Cell Physiol Biochem; 2017; 43(1):94-107. PubMed ID: 28848145
[TBL] [Abstract][Full Text] [Related]
13. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis.
Zhang S; Zhong J; Guo D; Zhang S; Huang G; Chen Y; Xu C; Chen W; Zhang Q; Zhao C; Liu S; Luo Z; Lin C
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23380. PubMed ID: 37132394
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
Chun E; Lee KY
Biochem Biophys Res Commun; 2004 Mar; 315(3):771-9. PubMed ID: 14975768
[TBL] [Abstract][Full Text] [Related]
15. [Multidrug resistance mechanisms in cell line HL-60/VCR].
Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
[TBL] [Abstract][Full Text] [Related]
16. Multiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulation.
Aldonza MB; Hong JY; Alinsug MV; Song J; Lee SK
Oncotarget; 2016 Jun; 7(23):34395-419. PubMed ID: 27284014
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
Jin X; Mo R; Ding Y; Zheng W; Zhang C
Mol Pharm; 2014 Jan; 11(1):145-57. PubMed ID: 24261922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
